Literature DB >> 2050597

Time-dependent killing of Clostridium difficile by metronidazole and vancomycin.

P N Levett1.   

Abstract

Killing of Clostridium difficile by metronidazole and vancomycin was studied with a batch culture method. Pre-reduced 50 ml volumes of brain heart infusion broth containing one of a range of concentrations of either vancomycin or metronidazole were inoculated with approximately 10(6) cfu/ml of C. difficile. The cultures were incubated anaerobically at 35 degrees C for 24 h. Total viable counts and spore counts were performed with a modified Miles and Misra technique. Concentrations of metronidazole and vancomycin below the respective MICs had no effect on the growth of C. difficile. A significant reduction in numbers of vegetative cells and spores occurred in the presence of concentrations of both agents close to their respective MICs. A bacteriostatic effect was observed when vancomycin concentrations similar to those occurring in faeces following oral administration of the drug were used. In contrast, rapid killing of vegetative cells occurred over a wide range of metronidazole concentrations greater than the MIC.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2050597     DOI: 10.1093/jac/27.1.55

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  8 in total

1.  Analysis of vancomycin time-kill studies with Staphylococcus species by using a curve stripping program to describe the relationship between concentration and pharmacodynamic response.

Authors:  B H Ackerman; A M Vannier; E B Eudy
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

2.  Honokiol Restores Polymyxin Susceptibility to MCR-1-Positive Pathogens both In Vitro and In Vivo.

Authors:  Yan Guo; Xiaohong Lv; Yanling Wang; Yonglin Zhou; Na Lu; Xuming Deng; Jianfeng Wang
Journal:  Appl Environ Microbiol       Date:  2020-02-18       Impact factor: 4.792

3.  A Small Molecule-Screening Pipeline to Evaluate the Therapeutic Potential of 2-Aminoimidazole Molecules Against Clostridium difficile.

Authors:  Rajani Thanissery; Daina Zeng; Raul G Doyle; Casey M Theriot
Journal:  Front Microbiol       Date:  2018-06-06       Impact factor: 5.640

4.  Application of Oleanolic Acid and Its Analogues in Combating Pathogenic Bacteria In Vitro/Vivo by a Two-Pronged Strategy of β-Lactamases and Hemolysins.

Authors:  Yonglin Zhou; Yan Guo; Xiaodi Sun; Rui Ding; Yanling Wang; Xiaodi Niu; Jianfeng Wang; Xuming Deng
Journal:  ACS Omega       Date:  2020-05-12

5.  Impact of subinhibitory concentrations of metronidazole on proteome of Clostridioides difficile strains with different levels of susceptibility.

Authors:  Tri-Hanh-Dung Doan; Stéphanie Yen-Nicolaÿ; Marie-Françoise Bernet-Camard; Isabelle Martin-Verstraete; Séverine Péchiné
Journal:  PLoS One       Date:  2020-11-09       Impact factor: 3.240

Review 6.  Risk Factors, Diagnosis, and Management of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease.

Authors:  Livio Enrico Del Vecchio; Marcello Fiorani; Ege Tohumcu; Stefano Bibbò; Serena Porcari; Maria Cristina Mele; Marco Pizzoferrato; Antonio Gasbarrini; Giovanni Cammarota; Gianluca Ianiro
Journal:  Microorganisms       Date:  2022-06-29

7.  Spore formation and toxin production in Clostridium difficile biofilms.

Authors:  Ekaterina G Semenyuk; Michelle L Laning; Jennifer Foley; Pehga F Johnston; Katherine L Knight; Dale N Gerding; Adam Driks
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

8.  Detection and Investigation of Eagle Effect Resistance to Vancomycin in Clostridium difficile With an ATP-Bioluminescence Assay.

Authors:  Angie M Jarrad; Mark A T Blaskovich; Anggia Prasetyoputri; Tomislav Karoli; Karl A Hansford; Matthew A Cooper
Journal:  Front Microbiol       Date:  2018-07-02       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.